Meet Zubair from Puttur who fought off Lashkar-e-Taiba militants in Kashmir

Bengaluru, Jul 16: Former union minister and Senior Congress leader Veerappa Moily on Wednesday said that if at all there is a political future for Sachin Pilot it is in the Congress party.

While speaking to news agency, Moily said Sachin Pilot achieved everything by being in Congress party.

"Sachin Pilot became MP, union minister in UPA-II, PCC president in Rajasthan and Deputy Chief Minister of Rajasthan. Whatever grievances you have, it needs to be resolved within the forum of the party. There is no hurry for Sachin Pilot. If at all there is a future for him it is in the Congress party. He has to realise that. He says he won't join BJP, it is good," Moily said.

The former Union Minister Moily further said that Pilot could not become Chief Minister as in Congress, the high command sends an observer and opinion of MLAs is ascertained, be it in Madhya Pradesh or Rajasthan.

"The leader who enjoys the support of elected MLAs is made Chief Minister," Moily said.
On July 14, Congress party had sacked Sachin Pilot from the post of Deputy Chief Minister of Rajasthan and also from PCC president.

The Rajasthan Congress is in turmoil over the past few days. State Chief Minister Ashok Gehlot has blamed the BJP for attempting to destabilise the state government by poaching MLAs. The Congress government in the state is facing a political crisis after simmering differences between Pilot and Ashok Gehlot came out in the open.

A controversy broke out in Rajasthan after Special Operation Group (SOG) sent a notice to Pilot to record his statement in the case registered by SOG in the alleged poaching of Congress MLAs in the state.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.